Pyoderma gangrenosum: An updated review

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 9, 2009, Pages 1008-1017

  Ruocco, E ^a   Sangiuliano, S ^a   Gravina, A G ^a   Miranda, A ^a   Nicoletti, G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Crohn's disease; Hyperergic reaction; Inflammatory bowel disease; Pathergy; Phag denisme g om trique; Pyoderma gangrenosum; Ulcerative colitis

Indexed keywords

ALEFACEPT; ALPHA INTERFERON; AZATHIOPRINE; BENZOYL PEROXIDE; CHLORAMBUCIL; CLOFAZIMINE; COLCHICINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; HEPARIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ISOTRETINOIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; MEZLOCILLIN; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINE; RIFAMPICIN; SULFAPYRIDINE; TACROLIMUS; THALIDOMIDE; UNINDEXED DRUG; VANCOMYCIN;

ACNE; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ARTHRITIS; BEHCET DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; COURSE EVALUATION; DERMATITIS HERPETIFORMIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ENTERITIS; EPIDEMIOLOGICAL DATA; ERYTHEMA; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LABORATORY TEST; LONG TERM CARE; LOW DRUG DOSE; MONOCLONAL IMMUNOGLOBULINEMIA; MONOTHERAPY; OPTIMAL DRUG DOSE; PARAPROTEINEMIA; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PYODERMA GANGRENOSUM; REVIEW; RHEUMATIC DISEASE; SKIN ALLERGY; SKIN ULCER; SPLEEN INFARCTION; SUBCORNEAL PUSTULAR DERMATOSIS; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; PYODERMA GANGRENOSUM;

EID: 68749094383     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03199.x     Document Type: Review

References (37)

1. Wolff K, Stingl G. Pyoderma gangrenosum. In : Freedberg IM, Eisen AZ, Wolff K et al., eds. Fitzpatrick's Dermatology in General Medicine, 5th edn. New York, NY : Mc Graw-Hill, 1999 2 : 2207 2213.
2. Brocq L. Nouvelle contribution a l'étude du phagédé nisme géométrique. Ann Dermatol Syphiligr 1916 6 : 1 39.
3. Brunsting AL, Goeckerman WH, O'Leary PA. Pyoderma gangrenosum: clinical and experimental observation in five cases occurring in adults. Arch Dermatol Syphilol, 1930 22 : 655 680.
4. Bolognia JL, Jorizzo JL, Rapini RP, eds. Pyoderma gangrenosum. Dermatology. London, UK : Mosby, 2003 1 : 415 418.
5. Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004 43 : 790 800.
6. Conrad C, Trüeb RM. Pyoderma gangrenosum. J Dtsch Dermatol Ges 2005 3 : 334 342.
7. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol, 1996 34 : 395 409.
8. O'Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 1978 114 : 1061 1064.
9. Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 1972 106 : 901 905.
10. Wilson-Jones E, Winkelmann RK. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988 18 : 511 521.
11. Perry HO, Winkelmann RK, Muller SA, Kierland RR. Malignant pyodermas. Arch Dermatol 1968 98 : 561 576.
12. Gibson LE, Daoud MS, Muller SA, Perry HO. Malignant pyodermas revisited. Mayo Clin Proc 1997 72 : 734 736.
13. Lyon CC, Smith AJ, Beck MH et al. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 2000 42 : 992 1002.
14. Tjandra JJ, Hughes LE. Parastomal pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum, 1994 37 : 938 942.
15. Hughes AP, Jackson JM, Callen JP. Clinical features and treatment of peristomal pyoderma gangrenosum. J Am Med Assoc 2000 284 : 1546 1548.
16. Callen JP. Pyoderma gangrenosum. Lancet 1998 351 : 581 585.
17. Van der Sluis I. Two cases of pyoderma (ecthyma) gangrenosum associated with the presence of an abnormal serum protein (beta2A-paraprotein): with a review of the literature. Dermatologica 1966 132 : 409.
18. Bonamigo RR, Behar PR, Beller C, Bonfá R. Pyoderma gangrenosum after silicone prosthesis implant in the breasts and facial plastic surgery. Int J Dermatol 2008 47 : 289 291.
19. Tinoco MP, Tamler C, Maciel G, Soares D, Avelleria JC, Azulay D. Pyoderma gangrenosum following isotretinoin therapy for acne nodulocystic. Int J Dermatol 2008 47 : 953 956.
20. Cook TJ, Lorincz AL. Pyoderma gangrenosum appearing 10 years after colectomy and apparent cure of chronic ulcerative colitis. Arch Dernatol, 1962 55 : 105 106.
21. Holmlund DEW, Wahlby L. Pyoderma gangrenosum after colectomy for inflammatory bowel disease. Acta Chir Scand 1987 53 : 73 74.
22. Ilter N, Adişen E, Gürer MA, Kevlekçi C, Tekin Ö, Sayin A. Dermatitis artefacta masquerading as pyoderma gangrenosum. Int J Dermatol 2008 47 : 975 977.
23. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis, part Ill, complications. Gut 1964 5 : 1 15.
24. Russell B. Phagedenic and gangrenous ulceration of the skin complicating ulcerative colitis. (Phagedena Geometricum). Br J Dermatol 1950 62 : 114 124.
25. Johnson ML, Wilson HTH. Skin lesions in ulcerative colitis. Gut 1969 10 : 255 263.
26. Thornton JR, Teague RH, Lon-Beer TS, Read AE. Pyoderma gangrenosum and ulcerative colitis. Gut 1979 21 : 247 248.
27. John B-J. Pyoderma gangrenosum. In : Lebwohl M, Heymann WR, Berth-Jones J, Coulson I, eds. Treatment of Skin Disease. London, UK : Mosby, 2002 : 544 547.
28. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RKS. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 1991 78 : 676 678.
29. Hamblin TJ. Pyoderma gangrenosum. Lancet 1998 351 : 1134.
30. Nguyen LQ, Weiner J. Treatment of pyoderma gangrenosum with benzoyl peroxide. Cutis 1977 19 : 842 844.
31. Tamir A, Landau M, Brenner S. Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum. Dermatology 1996 192 : 252 254.
32. Wolf R, Ruocco V. Nicotine for pyoderma gangrenosum. Arch Dermatol 1998 134 : 1071 1072.
33. Mimouni D, Anhalt GJ, Kouba DJ, Nousari HC. Infliximab for peristomal pyoderma gangrenosum. Br J Dermatol 2003 148 : 813 816.
34. Romero-Gomez M, Sanchez-Munoz D. Infliximab induces remission of pyoderma gangrenosum. Eur J Gastroenterol Hepatol 2002 14 : 907.
35. Regueiro M, Valentine J, Plevy S et al. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003 98 : 1821 1826.
36. Brooklyn TN, Dunnill MG, Shetty A et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006 55 : 505 509.
37. Foss CE, Clark AR, Inabinet R, Camacho F, Jorizzo JL. An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum. J Eur Acad Dermatol Venereol 2008 22 : 943 949.